Prevention of moderate and severe ovarian hyperstimulation syndrome a guideline

被引：20

作者：

机构：

[1] Amer Soc Reprod Med, Practice Comm, Washington, DC USA

来源：

FERTILITY AND STERILITY | 2024年 / 121卷 / 02期

关键词：

Controlled ovarian stimulation; assisted reproductive technology; gonadotropins; risk; clomiphene citrate; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; ENDOTHELIAL GROWTH-FACTOR; FINAL OOCYTE MATURATION; HIGH-RISK PATIENTS; INTRAVENOUS ALBUMIN; GNRH AGONIST; EMBRYO-TRANSFER; DOPAMINE AGONIST; TREATMENT CYCLES;

D O I：

10.1016/j.fertnstert.2023.11.013

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. This systematic review aims to identify who is at high risk for developing ovarian hyperstimulation syndrome, along with evidence -based strategies to prevent it and replaces the document of the same name last published in 2016. (Fertil Sterile 2024;121:230-45. (c) 2023 by American Society for Reproductive Medicine.)

引用

页码：230 / 245

页数：16

共 117 条

[1] Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation [J].

Aghssa, Malek Mansour ;

Tarafdari, Azam Manshadi ;

Tehraninejad, Ensieh Shahrokh ;

Ezzati, Mohammad ;

Bagheri, Maryam ;

Panahi, Zahra ;

Mahdavi, Saeed ;

Abbasi, Mehrshad .

REPRODUCTIVE HEALTH, 2015, 12

[2] Gonadotrophin-releasing hormone antagonists for assisted reproductive technology [J].

Al-Inany, Hesham G. ;

Youssef, Mohamed A. ;

Ayeleke, Reuben Olugbenga ;

Brown, Julie ;

Lam, Wai Sun ;

Broekmans, Frank J. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04)

[3] Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients [J].

Al-Shawaf, T ;

Zosmer, A ;

Hussain, S ;

Tozer, A ;

Panay, N ;

Wilson, C ;

Lower, AM ;

Grudzinskas, JG .

HUMAN REPRODUCTION, 2001, 16 (01) :24-30

[4] Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].

Alvarez, Claudio ;

Marti-Bonmati, Luis ;

Novella-Maestre, Edurne ;

Sanz, Roberto ;

Gomez, Raul ;

Fernandez-Sanchez, Manuel ;

Simon, Carlos ;

Pellicer, Antonio .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937

[5]

Amir H, 2015, J REPROD MED, V60, P48

[6]

Anaya Y, 2018, J ASSIST REPROD GEN, V35, P297, DOI 10.1007/s10815-017-1074-4

[7] Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial [J].

Andersen, Anders Nyboe ;

Nelson, Scott M. ;

Fauser, Bart C. J. M. ;

Garcia-Velasco, Juan Antonio ;

Klein, Bjarke M. ;

Arce, Joan-Carles .

FERTILITY AND STERILITY, 2017, 107 (02) :387-+

[8] Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization [J].

Aramwit, Pornanong ;

Pruksananonda, Kamthorn ;

Kasettratat, Narat ;

Jammeechai, Karnphat .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (12) :1148-1153

[9] Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model [J].

Ashrafi, Mahnaz ;

Bahmanabadi, Akram ;

Akhond, Mohammad Reza ;

Arabipoor, Arezoo .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (05) :1145-1152

[10] Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during in vitro fertilization/intracytoplasmic sperm injection cycles [J].

Bassiouny, Yasmin A. ;

Dakhly, Dina M. R. ;

Bayoumi, Yomna A. ;

Salaheldin, Noha M. ;

Gouda, Hisham M. ;

Hassan, Ayman A. .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 140 (02) :217-222

← 1 2 3 4 5 6 7 8 9 10 →